Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1251 of 5804
-
Can a phone app lower blood pressure in African-Americans? new study aims to find out.
Disease control Recruiting nowThe purpose of this study is to test the hypertension (HTN) app-based intervention to see if it is more effective in improving uncontrolled HTN and HTN self-care among Africian-Americans from baseline to post-intervention (immediate, 3 months and 6 months post-intervention) as co…
Phase: NA • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
8 patients with β-thalassemia tracked for years after one-time cell therapy
Disease control ENROLLING_BY_INVITATIONThis is a study to evaluate the long-term safety and efficacy of CS-101 in participants who received CS-101 in study CS -101-01 (NCT06291961),No investigational drug product will be administered in the study.
Sponsor: CorrectSequence Therapeutics Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New hope for advanced cancers: first human trial of DXC008 begins
Disease control Recruiting nowThis is a phase I, open-label, first-in-human clinical study designed to evaluate the safety, tolerability, MTD, DLT, RP2D, the PK characteristics, preliminary anti-tumor activity, the immunogenicity of DXC008 in patients with prostate cancer and other solid tumors such as Ewing …
Phase: PHASE1 • Sponsor: Hangzhou DAC Biotechnology Co., Ltd. • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New study tracks Ravulizumab's impact on daily life in myasthenia gravis
Disease control Recruiting nowThe Polish multicentre observational (non-interventional) study aiming to collect data on the management and clinical outcomes of patients with gMG that received ravulizumab.
Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug aims to unload the heart in lung hypertension
Disease control Recruiting nowPulmonary arterial hypertension (PAH) is a progressive disease characterized by vascular remodelling resulting in elevated pressures in the pulmonary artery (PA). This elevated pressure ultimately leads to fulminant right heart failure. Current therapeutic options are limited and…
Phase: PHASE4 • Sponsor: Amsterdam UMC, location VUmc • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New drug cocktail aims to fight advanced colon cancer
Disease control Recruiting nowThis is a non-randomized, open-label, dose-escalation and dose-expansion phase I/II clinical study to evaluate the safety, tolerability, and efficacy of HCB101 in combination with Cetuximab/Bevacizumab, and FOLFOX/FOLFIRI in Advanced or Metastatic Colorectal Cancer. The trial con…
Phase: PHASE1, PHASE2 • Sponsor: Chang Gung Memorial Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New hope for CIDP: modified immune protein enters human testing
Disease control Recruiting nowCIDP is an autoimmune disease. This means that the body's germ fighting (immune) system attacks itself. In CIDP, the immune system attacks the protective covering around the nerves called myelin. Over time, these nerves lose their ability to send signals to the muscles in the bod…
Phase: PHASE2 • Sponsor: Takeda • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New stent aims to prevent stroke in patients with clogged brain arteries
Disease control Recruiting nowThis clinical trial is a prospective, multicenter, single-arm study. About 300 subjects undergoing rapamycin-eluting stent implantation will be enrolled based on the inclusion and exclusion criteria. The primary endpoint is the rate of any stroke or death within 1 month. Secondar…
Sponsor: The Affiliated Hospital of Qingdao University • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Sound waves take aim at recurrent prostate cancer
Disease control Recruiting nowThis study will investigate the efficacy of focal high intensity focused ultrasound (HIFU) in patients with localized radiorecurrent prostate cancer. This study will also investigate the change in participant quality of life after HIFU therapy as compared to before HIFU therapy.
Phase: PHASE2 • Sponsor: University of Florida • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New hope for fabry patients: experimental drug enters human trials
Disease control Recruiting nowThis Phase 1/2 first-in-human (FIH) study is designed to evaluate the safety, tolerability, pharmacokinetics (PK), and efficacy of HM15421 in patients with FD.
Phase: PHASE1, PHASE2 • Sponsor: GC Biopharma Corp • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Fish oil could boost birth weight in HIV-Positive moms
Disease control ENROLLING_BY_INVITATIONThis clinical trial aims to determine the effect of PUFA-n3 supplementation on birth weight, gestational length, and plasma inflammatory markers in pregnant women with HIV who are on antiretroviral therapy. The key questions this study seeks to answer are: 1. Will the neonates o…
Phase: NA • Sponsor: Instituto Nacional de Perinatologia Isidro Espinosa de los Reyes • Aim: Disease control
Last updated Jun 26, 2026 16:20 UTC
-
New cocktail of cancer drugs shows promise in early trial
Disease control OngoingThis study is open to adults with head and neck cancer. The purpose of this study is to find out whether combining different study medicines makes tumors shrink in people with head and neck cancer. The tested medicines in this study are antibodies that act in different ways agai…
Phase: PHASE1 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Drug-resistant typhoid in kids: does a two-drug combo speed up recovery?
Disease control CompletedThis randomized controlled trial evaluates the comparative efficacy of intravenous meropenem alone versus intravenous meropenem combined with oral azithromycin in children aged 6 months to under 5 years diagnosed with blood culture-confirmed extensively drug-resistant uncomplicat…
Phase: PHASE4 • Sponsor: Sheikh Zayed Medical College • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New radiation approach aims to slow cancer in the brain and spine
Disease control OngoingThe purpose of this study is to confirm the safety and efficacy of linac based Volumetric Modulated Arc Therapy (VMAT) for craniospinal irradiation (CSI) in solid tumor cancer patients with leptomeningeal metastasis. The primary aim is to determine if linac based VMAT CSI for lep…
Phase: NA • Sponsor: NYU Langone Health • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Bionic breast implant aims to bring back sensation after mastectomy
Symptom relief Recruiting nowThis trial seeks to establish whether or not touch sensation can be restored to the breast via neural stimulation. Data will also be obtained to inform future feasibility (including safety), efficacy, and acceptability trials.
Phase: NA • Sponsor: University of Chicago • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC
-
New pill shows promise in early lung cancer trial
Disease control Recruiting nowThis study is designed to evaluate safety and anti-tumor activity of DZD6008 in patients with advanced NSCLC with EGFR mutations.
Phase: PHASE1 • Sponsor: Dizal Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Can a cancer drug help people with HIV pause their daily meds?
Disease control OngoingThis study is designed to evaluate the safety and efficacy of pomalidomide in HIV-1-infected individuals on ART and to determine the impact of pomalidomide on virological control in people living with HIV during an analytical treatment interruption.
Phase: PHASE1, PHASE2 • Sponsor: University of Aarhus • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Hope for rare brain disorder: new drug trial targets Jordan's syndrome
Disease control OngoingThe primary objective of this study is to assess the efficacy, safety, and tolerability of BPN14770 in participants aged 9 to 45 years with JS.
Phase: PHASE2 • Sponsor: Shionogi • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
AI outperforms traditional tests for fatty liver diagnosis?
Diagnosis CompletedThis study evaluates the accuracy of artificial intelligence (AI) models using FibroScan and clinical data to predict hepatic fibrosis in Egyptian patients with metabolic-associated fatty liver disease (MAFLD). The performance of the AI models will be compared with conventional n…
Sponsor: Tanta University • Aim: Diagnosis
Last updated Jun 27, 2026 08:06 UTC
-
New hope for Hard-to-Treat myeloma: experimental drug tested in chinese patients
Disease control Recruiting nowThis study will evaluate the pharmacokinetics (PK), safety, and efficacy of cevostamab in participants with relapsed or refractory (R/R) multiple myeloma (MM).
Phase: PHASE1 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC